U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07265921) titled 'A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors' on Nov. 20.
Brief Summary: This is an open-label,multicenter phase I study to evaluate the safety,Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0609 in Adult Participants with Locally Advanced/Metastatic Solid Tumors
Study Start Date: Nov. 07
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Cancer
Intervention:
DRUG: SIM0609 for injection
Multiple dose levels of SIM0609 will be explored in dose escalation
DRUG: dose expansion of SIM0609 in CRC
1~3 dose levels of SIM0609 will be explored in dose expans...